 Donnelley Financial Solutions NYSE: DFIN, a leading risk and compliance company, today announced that Leading BioSciences, Inc. LBS, a drug development company focused on improving human health through therapeutic protection of the intestinal mucosal barrier, is working with DFIN to manage remote monitoring of their COVID-19 study. 